Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 6/2003

01-08-2003

Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland)

Authors: Karen Woodson, Joseph A. Tangrea, Teresa A. Lehman, Ramakrishna Modali, Kristin M. Taylor, Kirk Snyder, Philip R. Taylor, Jarmo Virtamo, Demetrius Albanes

Published in: Cancer Causes & Control | Issue 6/2003

Login to get access
Metadata
Title
Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (Finland)
Authors
Karen Woodson
Joseph A. Tangrea
Teresa A. Lehman
Ramakrishna Modali
Kristin M. Taylor
Kirk Snyder
Philip R. Taylor
Jarmo Virtamo
Demetrius Albanes
Publication date
01-08-2003
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 6/2003
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1024840823328

Other articles of this Issue 6/2003

Cancer Causes & Control 6/2003 Go to the issue

OriginalPaper

Case–control study of diet and other risk factors for gastric cancer in Hawaii (United States)

OriginalPaper

Physical activity and risk of endometrial cancer in a prospective cohort study (United States)

OriginalPaper

Lung cancer trends in young adults: an early indicator of progress in tobacco control (United States)

OriginalPaper

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico

OriginalPaper

Cancer incidence among male Swedish veterinarians and other workers of the veterinary industry: a record-linkage study

OriginalPaper

Ethylene oxide and breast cancer incidence in a cohort study of 7576 women (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits